AFTEX
Price
$12.49
Change
-$0.00 (-0.00%)
Updated
Nov 19 closing price
Net Assets
23.92B
EMOAX
Price
$11.46
Change
-$0.01 (-0.09%)
Updated
Nov 19 closing price
Net Assets
767.93M
Interact to see
Advertisement

AFTEX vs EMOAX

Header iconAFTEX vs EMOAX Comparison
Open Charts AFTEX vs EMOAXBanner chart's image
American Funds Tax-Exempt Bond A
Price$12.49
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets23.92B
Eaton Vance Municipal Opportunities A
Price$11.46
Change-$0.01 (-0.09%)
VolumeN/A
Net Assets767.93M
AFTEX vs EMOAX Comparison Chart in %
View a ticker or compare two or three
VS
AFTEX vs. EMOAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFTEX is a Hold and EMOAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AFTEX has more cash in the bank: 23.9B vs. EMOAX (768M). EMOAX pays higher dividends than AFTEX: EMOAX (3.27) vs AFTEX (3.02). AFTEX was incepted earlier than EMOAX: AFTEX (46 years) vs EMOAX (14 years). EMOAX (0.98) is less costly to investors than AFTEX (0.55). AFTEX initial investment is less costly to investors than EMOAX (3%) vs EMOAX (3%). AFTEX has a lower initial minimum investment than EMOAX: AFTEX (250) vs EMOAX (1000). EMOAX annual gain was more profitable for investors over the last year : 3.56 vs. AFTEX (0.31). EMOAX return over 5 years is better than : 3.00 vs. AFTEX (-7.02).
AFTEXEMOAXAFTEX / EMOAX
Total Expense Ratio0.550.9359%
Annual Report Gross Expense Ratio0.550.9856%
Fund Existence46 years14 years-
Gain YTD0.8073.91221%
Front Load4%3%115%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets23.9B768M3,112%
Annual Yield % from dividends3.023.2792%
Returns for 1 year0.313.569%
Returns for 3 years5.0614.5035%
Returns for 5 years-7.023.00-234%
Returns for 10 years-0.8613.14-7%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBINM24.180.09
+0.37%
Merchants Bancorp
MTSR70.50N/A
N/A
Metsera Inc
IBO0.44N/A
-0.45%
Impact BioMedical Inc.
AVTX17.48-0.52
-2.89%
Avalo Therapeutics
TIGR8.13-0.96
-10.56%
UP Fintech Holding Ltd